India Lifts Export Ban on Remdesivir and Its Component API
India's Directorate General of Foreign Trade moved its export policy for COVID-19 treatment drug remdesivir and its active pharmaceutical ingredient from “prohibited” to “restricted” in a June 14 notification. The export of the drug or its API against the drug's…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
advance authorizations will no longer need a separate authorization, the release said.